Meridian Wealth Advisors, LLC Astrazeneca PLC Transaction History

Meridian Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $274,235 - $327,929	-5,652 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $16,027 - $18,452	302 Added 5.64%	5,652 $310,000
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $230,585 - $295,908	5,350 New	5,350 $283,000
Q1 2019 May 07, 2019	SELL	$35.49 - $43.02 $12,421 - $15,057	-350 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $12,901 - $14,521	350 New	350 $13,000

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Meridian Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Meridian Wealth Advisors, LLC with notifications on news.